CTOs on the Move

Ra Medical

www.ramed.com

 
Advanced Excimer Laser-Based Vascular and Dermatological Therapies We are a medical device company leveraging our advanced excimer laser-based platform for use in the treatment of vascular and dermatological diseases. We believe our products enhance patients` quality of life by restoring blood-flow in arteries and clearing chronic skin conditions. We currently manufacture and market two lines of products: DABRA Catheter and Laser is cleared by the U.S. FDA as a tool for the minimally invasive endovascular treatment of vascular blockages resulting from lower extremity vascular disease, including peripheral artery disease (PAD) and critical limb ischemia (CLI). Pharos Excimer Laser is FDA ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.ramed.com
  • 2070 Las Palmas Drive
    Carlsbad, CA USA 92011
  • Phone: 760.804.1648

Executives

Name Title Contact Details

Similar Companies

Mosaic Life Care

Mosaic Life Care provides a wide range of acute care and outpatient services near you in St. Joseph, Maryville and Albany, MO, and the surrounding areas. A Mayo Clinic Care Network member.

Brook Health

Get personalized guidance and chat with live health experts any day of the year to help manage or prevent diabetes, lose weight, and boost energy levels

Simulation and Training Environment Laboratory

Simulation and Training Environment Laboratory is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Furiex

Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company’s products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections. It is also developing SYR-472, which is in Phase III clinical trials for the treatment of Type-2 diabetes. In addition, the company has rights to compounds in various stages of development and commercialization, which includes Nesina, Liovel, Oseni, and Kazano for the treatment of Type-2 diabetes, as well as Priligy for the treatment of premature ejaculation. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.

Adamas Pharmaceuticals, Inc.

Adamas Pharmaceuticals, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Emeryville, CA. To find more information about Adamas Pharmaceuticals, Inc., please visit www.adamaspharma.com